| Project/Area Number |
17K09231
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Medical and hospital managemen
|
|---|
| Research Institution | Gifu University |
|---|
Principal Investigator |
Yuichi Hayashi 岐阜大学, 医学部附属病院, 講師 (00392366)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
鈴木 昭夫 岐阜大学, 医学部附属病院, 准教授 (80775148)
|
|---|
| Project Period (FY) |
2017-04-01 – 2022-03-31
|
| Project Status |
Completed (Fiscal Year 2021)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2019: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2018: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | ポリファーマシー / 高齢者 / 多剤処方 / インセンティブ / 電子カルテ / インセンティブ付与制度 / 医療保険 / 保険制度 / 電子カルテシステム |
|---|
| Outline of Final Research Achievements |
Polypharmacy is a major problem for elderly patients in developed countries. Because adverse drug-related problems are increasing in the patients who received 5 or more drugs. Therefore, reducing the number of drugs is required. In Japan, public health insurance system decided the incentive for reduction the number of drugs for patients receiving 6 or more drugs in case of reduction for 2 or more drugs. We investigated the efficacy of this incentive in public health insurance system. There is an effectiveness for especially in diabetic elderly patients with polypharmacy.
|
| Academic Significance and Societal Importance of the Research Achievements |
高齢者のポリファーマシーの是正に対しては、一部の多剤処方高齢者では、保険制度上のインセンティブ付与制度は、有用に働いている。高齢者のポリファーマシーの是正の１つの方法として、保険制度上のインセンティブ付与制度が有益であると考えられ、今後も増える高齢者の医療対策の１つとして存続すべき意義のある制度と考えた。
|
